Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ertapenem for Initial Empirical Treatment of Third Generation Cephalosporin Resistant Enterobacteriaceae Bacteremia: a Propensity Score Analysis

NCT03925402 is registered in ClinicalTrials.gov with Phramongkutklao College of Medicine and Hospital as lead sponsor.

NCT NCT03925402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03925402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ertapenem for Initial Empirical Treatment of Third Generation Cephalosporin Resistant Enterobacteriaceae Bacteremia: a Propensity Score Analysis
Lead sponsor
Phramongkutklao College of Medicine and Hospital
Phase
Observational
Overall status
Completed
Start date
May 15, 2019
Completion date
October 1, 2022
Enrollment
427 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bacteremia, infection, bacterial